Skip to main content

Partnership with Eckert & Ziegler AG and PentixaPharm GmbH

06 july 2023
microfluidic, radiopharmaceutical, therapy, iMiDEV, iMiGiNE

After promising results obtained on the iMiDEV microfluidic synthesizer, Eckert & Ziegler, Pentixapharm and PMB announce their partnership on an innovative project. The three companies have signed a letter of intent demonstrating their willingness to collaborate together in order to offer a cutting-edge solution for the synthesis of radiopharmaceuticals for the therapy.

 

For more information : Press release